$3.25B in CY2024 Part D spend3.7M claims · 931K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Evolocumab used for?
Evolocumab dramatically lowers LDL cholesterol by blocking the PCSK9 protein.
Is there a generic for Evolocumab?
No. Evolocumab is brand-only with no generic equivalents currently in market.
How much does my plan pay for Evolocumab?
Across 329 Part D plans, Evolocumab averages $281.60/unit (NADAC). Lowest available: $281.24/unit. Highest in distribution: $281.95/unit.
Is Evolocumab on the FDA shortage list?
No. Evolocumab is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (4 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.